Сравнение
Dulaglutide vs. Maridebart Cafraglutide
Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.
Идентичность
Категория
Метаболизм
Метаболизм
Номер CAS
923950-08-7
нет данных
Молекулярная масса
59670 g/mol
нет данных
Период полувыведения
110 h
нет данных
Последовательность
GLP-1(7-37)-Variante kovalent verbunden mit modifiziertem humanen IgG4-Fcнет данных
Механизм действия
Dulaglutide
Dulaglutide consists of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc. The Fc fusion increases molecular weight substantially (~60 kDa), reduces renal filtration and extends the half-life to several days. GLP-1 receptor activation glucose-dependently stimulates insulin secretion, inhibits glucagon, delays gastric emptying and modulates central satiety signalling.
Maridebart Cafraglutide
MariTide combines GLP-1 receptor agonism with GIP receptor antagonism in an antibody-peptide conjugate. Its long duration of action allows infrequent (monthly) dosing.
Доказательная база
Наивысшая доказательность
РКИ на людях
РКИ на людях
Исследования
5
1
из них на людях
5
1
Зафиксированные эффекты
3
2
Открытые противоречия
1
0
Задокументированные нежелательные явления
2
1
Правовой статус
Полные записи
Frequently asked questions
- What is the difference between Dulaglutide and Maridebart Cafraglutide?
- Dulaglutide is classified as "Метаболизм", while Maridebart Cafraglutide is classified as "Метаболизм". Dulaglutide: GLP-1 receptor agonist designed as a fusion protein of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc fragment. FDA-approved 2014 (Trulicity) for type 2 diabetes; EMA approval 2014. Maridebart Cafraglutide: Maridebart cafraglutide (MariTide, Amgen) is a bispecific molecule: a GLP-1 receptor agonist combined with a GIP receptor antagonist, designed for monthly dosing; in phase 3 for obesity. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Dulaglutide or Maridebart Cafraglutide?
- The highest available evidence level is "РКИ на людях" for Dulaglutide and "РКИ на людях" for Maridebart Cafraglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Dulaglutide and Maridebart Cafraglutide in Germany and the United States?
- Германия: Dulaglutide — Рецептурный, Maridebart Cafraglutide — Не одобрено. США: Dulaglutide — Рецептурный, Maridebart Cafraglutide — Не одобрено. These are factual summaries with source and review date on the individual pages.